Embryo transfer in no cycling Crioula and Quarter horse breeds treated with estradiol cipionate and long-acting progesterone

AUTOR(ES)

Kaercher, Fernanda, Siqueira, Marlon, Mercadante, Alessandro, Figueiredo, Tatiana, Weiss, Romildo Romualdo, Siqueira, Felipe, Kozicki, Luiz Ernandes

FONTE

Brazilian Archives of Biology and Technology

DATA DE PUBLICAÇÃO

2011-12

RESUMO

The aim of this work was to prepare the mares for embryo transfer. In group 1 (G1,treated, n=15), recipient mares in anoestrus or in a transition period were treated with 5.0, 3.0 and 2.0 mg of estradiol cipionate at the days 0, 1 and 2 respectively, beginning at the day of ovulation (DO). From the fourth day on, the mares this group received long-acting progesterone weekly, up to the 120 day of gestation. At D8, the embryo was collected from the donor and transferred to the recipient. At D12, the ultrasonographyc diagnosis of pregnancy was carried out. The control group (G2, not treated, n=20) was formed by cycling recipient mares, displaying ovulation at each 2 to 3 days after the donors mare ovulation. The pregnancy rate was higher (p<0.05) in the mares from G2 (85.0%) than from G1 (53.3%). Thus, it could be concluded that the treated mares although showed lesser pregnancy rate than the cycling mare, were satisfactory alternative to be used mainly when there is no available cycling recipient.

Documentos Relacionados

• Use of long-acting progesterone to acyclic embryo recipient mares
• Unique long-acting antiglucocorticoid in whole and broken cell systems.
• Allergy—Important Advances in Clinical Medicine: Long-Acting Theophyllines
• Perspectives on long-acting growth hormone therapy in children and adults
• Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin.